Gattefossé Takes Measures, Continues Operations during COVID-19 Pandemic

Gattefossé is working to ensuring the protection of its employees and to manufacturing and delivering, as far as possible, its products to its customers despite the health crisis.

Wherever Gattefossé operates, the company ensures compliance with national measures while maintaining working conditions in all its offices.

Gattefossé's partners and suppliers ensuring a regular supply, the company remains able to manufacturing and delivering its products, in particular those intended to drug manufacturers.

All the Group's affiliates are operational, working remotely. Only the Chinese affiliate has reopened its office, in accordance with current national provisions. Equipped with an application laboratory, Gattefossé China is supporting those that are currently closed in France, the United States and India.

As part of the Pharmaceutical value chain as supplier of excipients, the whole company is mobilized to offer its customers the best possible services and assistance given the exceptional situation.

In Saint-Priest (near Lyon), where the Group's headquarters and main production site are located, Gattefossé applies all the measures and recommendations suggested by authorities in France:

• Since March 17, all employees who have the possibility and whose presence is not mandatory on-site are working from their homes
• Only the production, supply chain, quality control and technical services are operating on-site with reduced staff, and in full compliance with sanitary measures. Members of the executive committee ensure a daily permanence in rotation
• Increased frequency of cleaning in frequented areas on site
• Implementation of health security measures and barrier actions for all employees operating on-site: masks distribution, manufacture of hydroalcoholic gel, individual offices, closure of the company restaurant and application of strict health instructions for meals
• Travel ban and postponement of all internal and professional events until further notice
• No external visits allowed

CPhI China 2020 To Be Postponed to Dec. 16-18th,

Register as Visitor to the 20th Edition of CPhI China!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.